Strategic partnerships Leverage Eurobio Scientific’s established distribution partnerships with Seegene, Canhelp Genomics, CareDx and ABL Diagnostics to cross-sell complementary diagnostic solutions and expand reach in oncology, infectious diseases, and transplant testing.

Expanding portfolio Target opportunities around Eurobio’s growing portfolio in transplantation, infectious diseases, life sciences reagents, and cancer diagnostics, emphasizing bundled offerings that combine proprietary assays with automated solutions from partner manufacturers.

Market leadership Position products as French market leaders in in vitro diagnostics and HLA testing to healthcare providers, laboratories, and transplant centers, highlighting quality manufacturing in a controlled cleanroom and in-house production capabilities.

Automation and automation-ready Highlight exclusive automated tests and solutions from partner suppliers to labs seeking workflow automation, high-throughput capabilities, and standardized quality controls, aligning with Eurobio’s integrated production and distribution strengths.

Growth opportunities Capitalize on recent revenue growth and ongoing market expansion by targeting hospitals and private labs with tailored value propositions, including dermatophyte PCR kits, oncology diagnostics, and next-generation sequencing/viral genotyping offerings through Eurobio’s network.